Brain Radiomodulation with BBB-Targeted Radiosensitizer Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Radiosurgery for neuronal modulation is challenging due to the difficulty in precisely targeting specific brain areas without affecting adjacent critical anatomy, leading to potential side effects and lack of selective neuronal alteration.

Innovation Solution

Combining anatomically targeted radiomodulation with systemically administered molecules that have high affinity for certain neuronal types, using methods like ultrasound to deliver radiosensitizers and radioprotectants to specific brain regions, temporarily opening the blood-brain barrier, and conjugating molecules with cell-type specificity to enhance therapeutic selectivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If highly collimated beams of ionizing radiation are used for radiosurgical neuromodulation, then anatomic specificity is improved, but radiation spreads into non-targeted tissue causing injury to critical anatomy

Engineering Contradiction:
Improveanatomic specificityVSAvoidradiation injury to critical structures
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by creating spatially heterogeneous distributions of radiosensitizers and radioprotectants. Radiosensitizers are concentrated in the target brain region to enhance radiation effects, while radioprotectants are concentrated in adjacent critical structures to prevent radiation damage. This local differentiation of chemical properties allows selective modulation of radiation effects in different spatial locations, resolving the contradiction between achieving precise anatomic targeting and avoiding injury to nearby critical anatomy.

Inventive Principle:
Principle #3Local quality

2Manufacturing precision

If radiosensitizers and radioprotectants are delivered systemically, then therapeutic selectivity is improved, but non-targeted uptake causes widespread effects

Engineering Contradiction:
Improvetherapeutic selectivityVSAvoidnon-targeted uptake
Core Design Contradiction:
Manufacturing precisionVSQuantity of substance

Solution Approach 1:

The patent employs blood-brain barrier disruption as an intermediary mechanism to enable selective delivery of radiosensitizers and radioprotectants. By temporarily disrupting the blood-brain barrier in specific brain regions using focused ultrasound or other methods, the system allows these molecules to enter the brain parenchyma selectively at target and critical structure locations. This intermediary step converts systemic administration into localized delivery, achieving therapeutic selectivity without widespread non-targeted uptake.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If ionizing radiation is delivered to alter neuronal activity, then functional modulation is achieved, but nearby critical structures are irradiated and injured

Engineering Contradiction:
Improvefunctional modulationVSAvoidinjury to critical structures
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by administering radioprotectants to critical structures before delivering ionizing radiation. The radioprotectants are delivered and allowed to accumulate in the critical anatomy adjacent to the target region. Only after this protective preparation is in place is the radiation delivered. This sequential timing ensures that when radiation reaches the critical structures, the radioprotectants are already positioned to mitigate harmful effects, thereby preserving functional modulation reliability while preventing injury.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Achieves safer and more effective neuronal modulation by selectively altering targeted brain areas while protecting nearby critical structures, treating disorders such as chronic pain, hyperphagia, and drug addiction with reduced side effects.

Implementation Method 1

delivery of these agents may be accomplished by anatomically specific methods, for example, by use of ultrasound. In some such embodiments, methods utilize targeted focused ultrasound with systemically infused microbubbles to temporarily open the blood-brain barrier

Methodology Applied
Scientific EffectFocused ultrasound: Ultrasound

Implementation Method 2

Radiomodulation (RM, radiosurgical neuromodulation) involves the use of radiosurgery to alter neuronal activity without killing cells or producing a lesion

Methodology Applied
Scientific EffectIonizing radiation: Radiation

Data Source

PatentUS20260034384A1Radiosurgical neuromodulation close to critical structures
Publication Date: 2026.02.05 ZAP SURGICAL SYSTEMS INC
  • US20260034384A1 patent drawing
  • US20260034384A1 patent drawing
  • US20260034384A1 patent drawing

AI summary

Methods of treatment and treatment systems for performing radiomodulatory stereotactic radiosurgery to treat brain disorders in which target neural tissues associated with the brain disorder are sensitized to radiation by administration of a molecular substance and/or non-targeted critical structures are protected from radiation by a molecular substance, in order to treat disorders of brain circuitry. Specific embodiments disclose means for treating pain, obesity and drug addiction.